Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile
Jad M. Abdelsattar, MD

@jad_sattar

Assistant Professor of Surgery University of Arizona|Board Certified Fellowship Trained Breast Surgical Oncologist|Author of “Mayo Clinic General Surgery”🏳️‍🌈

ID: 77309849

linkhttps://www.linkedin.com/in/jadabdelsattar calendar_today25-09-2009 21:00:34

4,4K Tweet

8,8K Followers

7,7K Following

Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

Structured Exercise should be prescribed for ANY cancer patient at any phase of treatment. I have this discussion with all my cancer patients before surgery. It’s amazing the amazing lifestyle changes they’ve made when we see each other at follow up! nejm.org/doi/full/10.10…

Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

More exciting data, B51 published. No need for RNI in T1-T3 N1 M0 breast CA following NAC with ypN0! We are in an area of de-escalation. #bcsm #breastcancer nejm.org/doi/full/10.10…

Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

IMpassion031 trial: Atezolizumab + NAC in TNBC 🔼 pCR rates & EFS, DFS, & OS, though not stat sig. ctDNA clearance 📶 with pCR & long-term outcomes, persistent ctDNA post-surgery predicted worse prognosis: time for personalised immunotherapy approaches! nature.com/articles/s4159…

Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

8 years ago 49 souls were lost at Pulse nightclub. There was no rhyme nor reason for it, except that we live in a world where there remains HATE toward us. What emerged from this is a powerful song that rang: “feel my pulse…it beats as hard as yours” facebook.com/share/p/14DTuY…

Breastcancer.org (@breastcancerorg) 's Twitter Profile Photo

People diagnosed with metastatic HER2-positive #breastcancer who received Enhertu and Perjeta as a first treatment had a lower risk of the cancer growing or death than people who received the standard of care Taxol-Herceptin-Perjeta (THP) regimen. #ASCO2025 Read more 🔗

People diagnosed with metastatic HER2-positive #breastcancer who received Enhertu and Perjeta as a first treatment had a lower risk of the cancer growing or death than people who received the standard of care Taxol-Herceptin-Perjeta (THP) regimen. #ASCO2025

Read more 🔗
Jennifer Plichta MD (she/her) (@jenniferplichta) 's Twitter Profile Photo

🧐While we await EUROPA, retrospective data suggests that monotherapy with endocrine or radiation therapy may be reasonable for older women with early stage #breastcancer! 🙌🙌 Great study by Tori Chanenchuk and Duke Cancer Duke Surgery colleagues! 🤩 rdcu.be/epNyS

🧐While we await EUROPA, retrospective data suggests that monotherapy with endocrine or radiation therapy may be reasonable for older women with early stage #breastcancer! 🙌🙌 Great study by <a href="/tchanenchuk/">Tori Chanenchuk</a> and <a href="/DukeCancer/">Duke Cancer</a> <a href="/DukeSurgery/">Duke Surgery</a>  colleagues! 🤩 rdcu.be/epNyS
Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

Great read on utility of #ArtificialInteligence in the multidisciplinary management of breast cancer patients. Yes #AI is exciting but I do not believe that it can replace decades of experience in the field and human reasoning.

Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

Tonight was the happiest night of my life. We got to see Coldplay in concert in Denver, Colorado. The show must go on despite the fact that it started raining, and Chris Martin did not disappoint (sorry man, I know you said don’t post but I had to, this is too good!) #Coldplay

Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

Chris Martin is a rare raw talent that shines like a bright star 🌟 Vocals live were better than recorded versions, just take a listen. The concert is the best I’ve ever been to in Denver, Colorado and it just uplifts your spirit and soul, an incredible feeling of love and

Akiko Chiba, MD, FACS (@chibaakiko) 's Twitter Profile Photo

Do you routinely localized clipped node after NAC in cN+ disease? I do! 🙋🏻‍♀️ 10% of clipped node was non-SLN and 60% clipped node had residual disease 👇🏼👇🏼👇🏼

Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

This popped up on Facebook memories. 15 years ago, my sister & I stood in Times Square while my mom snapped a moment in time. It has been years, but we text each other all the time. Life is fleeting, I love her & I am proud of her for becoming a family medicine specialist in

This popped up on Facebook memories. 15 years ago, my sister &amp; I stood in Times Square while my mom snapped a moment in time. It has been years, but we text each other all the time. Life is fleeting, I love her &amp; I am proud of her for becoming a family medicine specialist in
Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

Post-treatment MRI in ILC underestimated size in 52.5% of cases, NME ⏫️ underestimation mean = 3.4 cm❗️+ ⏫️ + margins. Even with complete imaging response, 93.3% ❗️had residual invasive disease on pathology! We need additional imaging features ⚠️ link.springer.com/article/10.124…

Society of Surgical Oncology (@socsurgonc) 's Twitter Profile Photo

New weekly Annals of Surgical Oncology featured the article — An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons: ow.ly/t1Ms50WrUzS

New weekly Annals of Surgical Oncology featured the article — An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons: ow.ly/t1Ms50WrUzS
Jad M. Abdelsattar, MD (@jad_sattar) 's Twitter Profile Photo

DESTINY-Breast09 phase 3: trastuzumab deruxtecan (T-DXd; Enhertu) with pertuzumab as first-line treatment for HER2-positive locally advanced or metastatic breast cancer improved progression free survival by 44% compared to current SOC THP per CLEOPATRA! cancernetwork.com/view/t-dxd-gra…